اوریتاوانسین (Persian Wikipedia)

Analysis of information sources in references of the Wikipedia article "اوریتاوانسین" in Persian language version.

refsWebsite

Global rank Persian rank

5,389^th place

low place

2^nd place

2^nd place

4^th place

5^th place

447^th place

382^nd place

68^th place

179^th place

doi.org

Domenech O, Francius G, Tulkens PM, Van Bambeke F, Dufrêne Y, Mingeot-Leclercq MP (September 2009). "Interactions of oritavancin, a new lipoglycopeptide derived from vancomycin, with phospholipid bilayers: Effect on membrane permeability and nanoscale lipid membrane organization" (PDF). Biochimica et Biophysica Acta. 1788 (9): 1832–40. doi:10.1016/j.bbamem.2009.05.003. PMID 19450541.

europa.eu

ema.europa.eu

"Orbactiv". 2018-09-17.

fda.gov

News Release (6 August 2014). "FDA approves Orbactiv to treat skin infections". FDA.

nih.gov

pubmed.ncbi.nlm.nih.gov

Domenech O, Francius G, Tulkens PM, Van Bambeke F, Dufrêne Y, Mingeot-Leclercq MP (September 2009). "Interactions of oritavancin, a new lipoglycopeptide derived from vancomycin, with phospholipid bilayers: Effect on membrane permeability and nanoscale lipid membrane organization" (PDF). Biochimica et Biophysica Acta. 1788 (9): 1832–40. doi:10.1016/j.bbamem.2009.05.003. PMID 19450541.

ucl.ac.be

farm.ucl.ac.be

Domenech O, Francius G, Tulkens PM, Van Bambeke F, Dufrêne Y, Mingeot-Leclercq MP (September 2009). "Interactions of oritavancin, a new lipoglycopeptide derived from vancomycin, with phospholipid bilayers: Effect on membrane permeability and nanoscale lipid membrane organization" (PDF). Biochimica et Biophysica Acta. 1788 (9): 1832–40. doi:10.1016/j.bbamem.2009.05.003. PMID 19450541.